相关实验视频

Updated: May 23, 2025

Isolation and Quantitative Evaluation of Brush Cells from Mouse Tracheas

Isolation and Quantitative Evaluation of Brush Cells from Mouse Tracheas

Published on: June 12, 2019

德泽佩卢马布抑制了慢性鼻炎中高度功能性截断的胸腺 stromal 淋巴蛋白

Aiko Oka¹, Aiko I Klingler², Masanori Kidoguchi³

¹Division of Allergy and Immunology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Ill; Department of Otolaryngology, International University of Health and Welfare, Narita, Chiba, Japan.

The Journal of allergy and clinical immunology

|March 8, 2025

概括

胸膜层淋巴蛋白 (TSLP) 驱动慢性鼻炎 (CRS) 的2型炎症. 泰塞佩卢马布有效抑制了TSLP.

科学领域:

免疫学免疫学免疫学
耳鼻喉科耳鼻喉科耳鼻喉科
分子生物学分子生物学

背景情况:

胸膜支流性淋巴蛋白 (TSLP) 和其切割形式涉及慢性鼻炎与鼻息肉 (CRSwNP) 的2型 (T2) 炎症.
TSLP在没有鼻息肉的CRS (CRSsNP) 中的作用和tzepelumab对切割的TSLP的疗效以前没有研究过.

研究的目的:

在CRSsNP和CRSwNP中调查tzepelumab对切割TSLP的影响.
确定TSLP在CRSsNP中的T2炎症中的作用.

主要方法:

使用定量RT-PCR测量TSLP和T2标记器mRNA在ethmoid组织 (ETs) 和鼻 (NP) 中.
切割的TSLP在体外使用组织提取物生成.
使用外周血液单核细胞 (PBMCs) 评估了Tzepelumab对TSLP诱导的髓状树突细胞 (mDCs) 和2组先天性淋巴细胞 (ILC2s) 激活的抑制作用.

主要成果:

在NP和T2CRSsNPET中,TSLPmRNA水平升高,与T2标志物有正相关性.
CRSsNP ET提取物产生了活性裂开的TSLP.
根据剂量,Tezepelumab抑制了mDCs和ILC2s的激活,这些激活是由全长TSLP和切割TSLP诱导的.

结论:

在CRSsNP和CRSwNP中,TSLP参与T2炎症.
采佩卢马布通过中和活性TSLP形式来证明T2 CRS的潜在治疗益处.

关键词:

这就是CRSsNP.在CRSwNP中使用.这是一种T2炎症.这是TSLP的TSLP.泰泽佩卢姆巴布 (Tezepelumab) 是一个小镇.慢性鼻鼻炎是什么鼻腔多重体是指鼻腔多重体.后翻译修改后的修改.

更多相关视频

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Published on: August 30, 2014

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity

Published on: January 7, 2019

相关概念视频

T Cell Types and Functions

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

Drugs Used in Lower Respiratory Disorders: Overview

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...